Factors associated with leakage after reversal of protective stoma in patients with locally advanced rectal cancer following curative resection and anastomosis.

IF 3.5 2区 医学 Q2 ONCOLOGY Ejso Pub Date : 2024-09-17 DOI:10.1016/j.ejso.2024.108698
Miao-Ling Tsai, Ji-Shiang Hung, John Huang, Been-Ren Lin
{"title":"Factors associated with leakage after reversal of protective stoma in patients with locally advanced rectal cancer following curative resection and anastomosis.","authors":"Miao-Ling Tsai, Ji-Shiang Hung, John Huang, Been-Ren Lin","doi":"10.1016/j.ejso.2024.108698","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Anastomotic leakage (AL) is a significant complication in colorectal surgery with numerous general and specific risk factors. The determinants of colorectal AL following the reversal of a protective defunctioning ileostomy remain unclear and warrant further investigation.</p><p><strong>Material and methods: </strong>Data from April 2008 to December 2014 were collected and retrospectively reviewed for 361 consecutive patients who underwent protective ileostomy reversal following curative resection with anastomosis for rectal cancer. The baseline, treatment, and oncological variables of patients associated with post-reversal AL were evaluated using univariate and multivariate logistic regression analysis. The impact of AL on long-term survival outcomes was assessed using Kaplan-Meier survival analyses.</p><p><strong>Results: </strong>In a study of 361 patients, 52 (14.4 %) experienced leakage following stoma reversal, manifesting at a median of 5.7 months. Multivariable logistic regression analysis revealed that an anastomosis located less than 7 cm from the anal verge (OR 2.82, p = 0.008), a side-to-end anastomotic configuration (OR 2.02, p = 0.036), involvement of the circumferential resection margin (OR 6.46, p = 0.043), and adjuvant radiotherapy (OR 4.69, p = 0.003) significantly predicted post-reversal AL. Notably, five-year overall survival (63.4 % vs. 90.3 %, p < 0.0001) and disease-free survival (46.9 % vs. 71.1 %, p = 0.001) were significantly lower in patients with post-reversal AL.</p><p><strong>Conclusions: </strong>Our analysis identified several clinicopathological factors associated with post-reversal AL, which is linked to a significant decrease in long-term survival and oncological outcomes. Alleviating these adverse effects necessitates ensuring early detection and effective management of leaks among high-risk patients.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejso","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejso.2024.108698","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Anastomotic leakage (AL) is a significant complication in colorectal surgery with numerous general and specific risk factors. The determinants of colorectal AL following the reversal of a protective defunctioning ileostomy remain unclear and warrant further investigation.

Material and methods: Data from April 2008 to December 2014 were collected and retrospectively reviewed for 361 consecutive patients who underwent protective ileostomy reversal following curative resection with anastomosis for rectal cancer. The baseline, treatment, and oncological variables of patients associated with post-reversal AL were evaluated using univariate and multivariate logistic regression analysis. The impact of AL on long-term survival outcomes was assessed using Kaplan-Meier survival analyses.

Results: In a study of 361 patients, 52 (14.4 %) experienced leakage following stoma reversal, manifesting at a median of 5.7 months. Multivariable logistic regression analysis revealed that an anastomosis located less than 7 cm from the anal verge (OR 2.82, p = 0.008), a side-to-end anastomotic configuration (OR 2.02, p = 0.036), involvement of the circumferential resection margin (OR 6.46, p = 0.043), and adjuvant radiotherapy (OR 4.69, p = 0.003) significantly predicted post-reversal AL. Notably, five-year overall survival (63.4 % vs. 90.3 %, p < 0.0001) and disease-free survival (46.9 % vs. 71.1 %, p = 0.001) were significantly lower in patients with post-reversal AL.

Conclusions: Our analysis identified several clinicopathological factors associated with post-reversal AL, which is linked to a significant decrease in long-term survival and oncological outcomes. Alleviating these adverse effects necessitates ensuring early detection and effective management of leaks among high-risk patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
局部晚期直肠癌患者治愈性切除和吻合术后逆转保护性造口后发生渗漏的相关因素。
介绍:吻合口漏(AL)是结直肠手术中的一个重要并发症,具有许多一般和特殊的风险因素。逆转保护性失功能回肠造口术后发生结直肠AL的决定因素仍不清楚,值得进一步研究:收集并回顾性审查了 2008 年 4 月至 2014 年 12 月期间连续接受保护性回肠造口逆转术的 361 例直肠癌根治性切除吻合术患者的数据。采用单变量和多变量逻辑回归分析评估了与逆转术后AL相关的患者基线、治疗和肿瘤学变量。采用 Kaplan-Meier 生存分析评估了 AL 对长期生存结果的影响:在对 361 名患者进行的研究中,52 人(14.4%)在造口翻转术后出现渗漏,中位时间为 5.7 个月。多变量逻辑回归分析显示,吻合口距离肛门边缘小于 7 厘米(OR 2.82,p = 0.008)、侧对端吻合口结构(OR 2.02,p = 0.036)、周缘切除边缘受累(OR 6.46,p = 0.043)和辅助放疗(OR 4.69,p = 0.003)可显著预测造口翻转术后 AL。值得注意的是,五年总生存率(63.4% vs. 90.3%,P=0.043我们的分析确定了与逆转后 AL 相关的几个临床病理因素,而逆转后 AL 与长期生存率和肿瘤预后的显著下降有关。要减轻这些不良影响,就必须确保早期发现并有效管理高危患者的漏诊。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Ejso
Ejso 医学-外科
CiteScore
6.40
自引率
2.60%
发文量
1148
审稿时长
41 days
期刊介绍: JSO - European Journal of Surgical Oncology ("the Journal of Cancer Surgery") is the Official Journal of the European Society of Surgical Oncology and BASO ~ the Association for Cancer Surgery. The EJSO aims to advance surgical oncology research and practice through the publication of original research articles, review articles, editorials, debates and correspondence.
期刊最新文献
Calendar of events Editorial Board Reply to: “Optimizing the clinical utilization of geriatric nutritional risk index in esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy” Optimizing the clinical utilization of geriatric nutritional risk index in esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy Letter to the editor: “Validation of a supplementary condition of eighth AJCC staging system for stage II hepatocellular carcinoma”
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1